The Use of GLP-1 Drugs for Weight Loss Goes Beyond Slimming. It’s Transforming the Economy.

The rise of GLP-1 weight-loss drugs such as Ozempic and Wegovy is set to redefine numerous sectors of the global economy. These drugs, originally developed for the treatment of diabetes, have demonstrated remarkable efficacy in weight loss, hence their widespread adoption. As their popularity grows, we can expect major shifts in the industries of food production, healthcare, insurance, apparel, fitness and leisure.